
Presented with

How can nonprofits use innovation to improve the journey for patients with rare diseases, from diagnosis to treatment and holistic care?
The Amgen Prize: Innovation for Patients with Rare Diseases
Closed
Submissions are closed
Timeline
-
Applications Open
April 29, 2024 9:30am EDT -
Solution Deadline
June 24, 2024 11:59am EDT -
Deadline to Submit (Extended)
June 24, 2024 11:59am EDT -
Reviews
July 14, 2024 11:59pm EDT -
Judging Round 1
July 29, 2024 11:59pm EDT -
Virtual Finalist Interviews
September 5, 2024 12:00pm EDT -
In-Person Finalist Interviews at Concordia, NYC
September 24, 2024 12:00pm EDT
Judges

Samuel Agyei Wiafe
Rare Disease Ghana Initiative, Founder and Executive Director

Michael Hund
EB Research Partnership, CEO

Nicole Boice
Global Genes / RARE-X, Founder & Chief Mission Officer

Nadia Bodkin
Rare Advocacy Movement, Founder

Catharine Smith
Termeer Foundation, Executive Director

Durhane Wong-Rieger
Canadian Organization for Rare Disorders, President & CEO

Casey McPherson
To Cure A Rose Foundation, Founder & Chairman of Board

Yasmeen Long
Milken Institute, FasterCures, Director

Barbara Goodman
Cures Within Reach, President & CEO

Diego Fernando Gil Cardozo
Enfermedades Raras del Caribe y América Latina (ERCAL), Executive Director

Annie Kennedy
EveryLife Foundation for Rare Diseases, Chief of Policy, Advocacy & Patient Engagement - EveryLife Foundation for Rare Diseases

Jill Pollander
National Organization for Rare Disorders (NORD), Vice President of Patient Services

Marshall Summar
Uncommon Cures, Chief Executive Officer
Gabriela M. Repetto
Facultad de Medicina, Clinica Alemana Universidad del Desarrollo, Santiago, Chile, Director, Rare Diseases Program

Karim Smaira
Genpharm, Founder and CEO
Aime Lumaka
African Rare Disease Initiative, Principal Investigator

Jenifer Ngo Waldrop
Rare Disease Diversity Coalition, Black Women's Health Imperative, Executive Director